Thomvest Asset Management Ltd. Makes Non-Binding Offer To Acquire Outstanding Shares Of Liminal BioSciences Inc. Other Than 64% Owned By Structured Alpha LP For $7.50/Share

Author: Benzinga Newsdesk | April 05, 2023 06:32am

Thomvest Asset Management Ltd. ("Thomvest") today announced that it has made a non-binding, all cash proposal (the "Proposal") to acquire the outstanding common shares ("Common Shares") of Liminal BioSciences Inc. (NASDAQ:LMNL) (the "Corporation"), other than the 64% owned by Structured Alpha LP ("SALP"), a limited partnership of which Thomvest is the sole general partner, for US$7.50 per Common Share. The proposal represents:

• a 107% premium to the closing price of the Common Shares on April 4, 2023;
• a 31% premium to the highest price at which the Common Shares traded during the period since the abandonment of the Corporation's Fezagepras clinical program; and
• a 44% premium to the volume-weighted average price of the Common Shares since the effectiveness of the 1-for-10 share consolidation.

Posted In: LMNL